Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice.
The human APOE4 allele is associated with an early age of onset and increased risk of Alzheimer's disease (AD). Apolipoprotein E is secreted as part of a high-density lipoprotein-like particle by glial cells in the brain for the primary purpose of transport of lipophilic compounds involved in the maintenance of synapses. Previous studies examining synaptic integrity in the amygdala of human apoE targeted replacement (TR) mice showed a decrease in spontaneous excitatory synaptic activity, dendritic arbor, and spine density associated with apoE4 compared with apoE3 and apoE2 in adult male mice. In the present study, we assessed how APOE genotype affects synaptic integrity of amygdala neurons by comparing electrophysiological and morphometric properties in human apoE3, E4, and E2/4 TR mice at the age of 18-20 months. In contrast to adult mice, we found that aged apoE4 TR mice exhibited the highest level of excitatory synaptic activity compared with other cohorts. Additionally, apoE4 mice had significantly greater spontaneous inhibitory activity than all other cohorts. Taken together, there was a significant interaction between genotypes when comparing inhibition relative to excitation; there was a simple main effect of frequency type with an imbalance toward inhibition in apoE4 mice but not in apoE3 or apoE2/4 mice. These results suggest that apoE isoforms differentially influence synaptic transmission throughout the life span, where aging coupled with apoE4 expression, results in an imbalance in maintaining integrity of synaptic transmission.
Department of Psychiatry, Duke University Medical Center, Durham, NC, USA; MIRECC, Durham Veterans Affairs Medical Center, Durham, NC, USA.
Rebecca C
RC
Klein
Department of Psychiatry, Duke University Medical Center, Durham, NC, USA; Neurobiology Research Lab, Durham Veterans Affairs Medical Center, Durham, NC, USA.
Shawn K
SK
Acheson
GRECC, Durham Veterans Affairs Medical Center, Durham, NC, USA; Department of Medicine (Geriatrics), Duke University Medical Center, Durham, NC, USA.
Brian E
BE
Mace
GRECC, Durham Veterans Affairs Medical Center, Durham, NC, USA; Department of Medicine (Geriatrics), Duke University Medical Center, Durham, NC, USA.
Patrick M
PM
Sullivan
Department of Psychiatry, Duke University Medical Center, Durham, NC, USA; MIRECC, Durham Veterans Affairs Medical Center, Durham, NC, USA. Electronic address: sdmoore@duke.edu.
Scott D
SD
Moore
D000483:Alleles; D000544:Alzheimer Disease / Q000235:genetics; D000679:Amygdala / Q000166:cytology / Q000502:physiology*; D000818:Animals; D053327:Apolipoprotein E4 / Q000235:genetics*; D055724:Electrophysiological Phenomena; D005838:Genotype; D006801:Humans; D008297:Male; D008822:Mice, Transgenic; D009474:Neurons / Q000502:physiology*; D012306:Risk; D009435:Synaptic Transmission / Q000235:genetics*
D053327:Apolipoprotein E4
Alzheimer's dementia; Amygdala; Apolipoprotein E; Synaptic